• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在老年受试者中,抑郁严重程度越高,与抑郁相关的认知缺陷改善越少。

Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects.

作者信息

Taylor Warren D, Wagner H Ryan, Steffens David C

机构信息

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, DUMC 3903, Durham, NC 27710, USA.

出版信息

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):632-5.

PMID:12213698
Abstract

OBJECTIVES

Elderly depressed patients often exhibit cognitive deficits, which may improve with drug therapy. The authors investigated the relationship of baseline depression severity and cognitive improvement with antidepressant treatment in depressed patients with mild cognitive impairment.

METHODS

Mini-Mental State Exam (MMSE) and Montgomery-Asberg Depression Rating Scale (MADRS) scores were measured in 52 depressed geriatric patients without dementia at baseline, 6, and 12 months, during an intent-to-treat period. A repeated-measures regression model tested the effect of MADRS score on MMSE.

RESULTS

MMSE changes were significant and linear over time, with an average increase of 0.72 in the MMSE per 6-month interval. The final model showed that for every point increase in baseline MADRS, the average 6-month increase in MMSE decreased by 0.12. Repeated MADRS measurements did not significantly alter its predictive value.

CONCLUSION

Greater baseline depression severity in older subjects with mild cognitive deficits is associated with less improvement in those deficits even with successful antidepressant therapy.

摘要

目的

老年抑郁症患者常表现出认知缺陷,药物治疗可能会改善这些缺陷。作者研究了轻度认知障碍抑郁症患者基线抑郁严重程度与抗抑郁治疗后认知改善之间的关系。

方法

在52例无痴呆的老年抑郁症患者的意向性治疗期间,于基线、6个月和12个月时测量简易精神状态检查表(MMSE)和蒙哥马利-艾斯伯格抑郁评定量表(MADRS)得分。重复测量回归模型检验了MADRS得分对MMSE的影响。

结果

MMSE随时间变化显著且呈线性,每6个月间隔MMSE平均增加0.72。最终模型显示,基线MADRS每增加1分,MMSE平均6个月增加量减少0.12。重复的MADRS测量未显著改变其预测价值。

结论

轻度认知缺陷的老年受试者基线抑郁严重程度越高,即使抗抑郁治疗成功,这些缺陷的改善也越少。

相似文献

1
Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects.在老年受试者中,抑郁严重程度越高,与抑郁相关的认知缺陷改善越少。
Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):632-5.
2
[The cognitive deficits in the late-life depression and their prognostic value for pharmacotherapy].[老年期抑郁症的认知缺陷及其对药物治疗的预后价值]
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):167-76.
3
Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study.阿尔茨海默病和路易体痴呆症中的抑郁症状:一项为期一年的随访研究。
Dement Geriatr Cogn Disord. 2011;32(2):143-9. doi: 10.1159/000332016. Epub 2011 Oct 5.
4
The role of tests of frontal executive function in the detection of mild dementia.额叶执行功能测试在轻度痴呆检测中的作用。
Int J Geriatr Psychiatry. 2001 Jan;16(1):18-26. doi: 10.1002/1099-1166(200101)16:1<18::aid-gps265>3.0.co;2-w.
5
Depressive symptoms and cognitive change in older Mexican Americans.老年墨西哥裔美国人的抑郁症状与认知变化
J Geriatr Psychiatry Neurol. 2007 Sep;20(3):145-52. doi: 10.1177/0891988707303604.
6
Cognitive Function in Older Suicide Attempters and a Population-Based Comparison Group.老年自杀未遂者的认知功能及基于人群的对照组比较
J Geriatr Psychiatry Neurol. 2016 May;29(3):133-41. doi: 10.1177/0891988715627015. Epub 2016 Jan 25.
7
Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.老年抑郁症患者使用帕罗西汀:与氟西汀在疗效、认知及行为影响方面的随机对照比较
Int Clin Psychopharmacol. 1994 Spring;9(1):25-9.
8
Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsy.在癫痫患者中使用自评工具与评估者实施的工具评估抑郁严重程度。
Epilepsy Behav. 2018 Aug;85:52-57. doi: 10.1016/j.yebeh.2018.05.018. Epub 2018 Jun 13.
9
Antidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage.老年有或无重性或轻度抑郁的内科患者中抗抑郁药物的使用与认知功能:一项前瞻性队列研究并与数据库关联。
J Clin Psychopharmacol. 2011 Aug;31(4):429-35. doi: 10.1097/JCP.0b013e318221b2f8.
10
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.双重双重作用?文拉法辛与米氮平联合治疗抑郁症。
Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

引用本文的文献

1
Different meanings of a three-point decline in MMSE score in Alzheimer's disease and depressive disorder.阿尔茨海默病和抑郁症中简易精神状态检查表(MMSE)评分三分下降的不同意义
BJPsych Open. 2024 Aug 8;10(5):e145. doi: 10.1192/bjo.2024.732.
2
Accelerated brain aging predicts impaired cognitive performance and greater disability in geriatric but not midlife adult depression.加速的大脑老化预示着老年而非中年成年抑郁症患者认知表现受损和残疾程度增加。
Transl Psychiatry. 2020 Sep 18;10(1):317. doi: 10.1038/s41398-020-01004-z.
3
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.
尼古丁与网络:改善老年期抑郁症患者心境和认知的潜力。
Neurosci Biobehav Rev. 2018 Jan;84:289-298. doi: 10.1016/j.neubiorev.2017.08.018. Epub 2017 Aug 30.
4
Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.多奈哌齐治疗认知障碍和抑郁的老年患者(DOTCODE 研究):临床原理与设计。
Contemp Clin Trials. 2014 Mar;37(2):200-8. doi: 10.1016/j.cct.2013.11.015. Epub 2013 Dec 5.
5
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.认知作为老年期抑郁症的治疗靶点:烟碱类药物治疗的潜力。
Biochem Pharmacol. 2013 Oct 15;86(8):1133-44. doi: 10.1016/j.bcp.2013.07.032. Epub 2013 Aug 8.
6
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.随机双盲安慰剂对照多奈哌齐增效治疗抗抑郁药治疗的老年抑郁症伴认知障碍患者:一项试点研究。
Int J Geriatr Psychiatry. 2008 Jul;23(7):670-6. doi: 10.1002/gps.1958.